TP53 and COVID-19: In multivariate analysis, three baseline factors emerged as significant and independent risk factors for developing COVID-19, age (HR: 0.97 [95% CI: 0.95–0.9995], p = 0.046), the number of prior treatments, ≥2 vs. 1 (HR: 2.08 [95% CI: 1.27–3.40], p = 0.004), the presence of TP53 deletion and, or mutation (HR: 1.85 [95% CI: 1.06–3.25], p = 0.032), (Supplementary Table S2).